THE POWER OF VIBRANCE
BSE SENSEX
77,414.92
-191.51 -0.25%
28 Mar 25 | 16:00 | Close

Get Quote

Onesource Specialty Pharma Ltd

0
(ONESOURCE | 544292 | INE013P01021)
1748.05 +44.25 (+2.60%)
28 Mar 25 | 16:00 | All Prices in   


Previous Close 1703.80
Open 1699.55
High 1763.00
Low 1680.10
VWAP 1,730.96
52 Wk High 1,774.30
52 Wk Low 1,163.05
Upper Price Band 2,097.65
Lower Price Band 1,398.45
Price Band 20%
TTQ 5677
Turnover (Lakh) 98.27
2W Avg Qty`(Lakh) 0.10
Mcap Full (Cr.) 20,003.99
Mcap FF (Cr.) 12,216.42
EPS (TTM) -
CEPS (TTM) -
PE/PB - / 49.14
ROE -27.78
Face Value 1.00
Category Listed
Group / Settlement Type B /T+1
Index -
Basic Industry Pharmaceuticals

Corporate Announcements
Segment :
Announcement Submission Type :
From Date
To Date
Category
Sub Category
     Current Page Number 1 out of 1
No of Announcements 31 Till Date 29 Mar 2025
 
Company : Onesource Specialty Pharma Ltd
29 Mar 2025
544292  |   Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Company Update 2.28 MB XBRL
Intimation on completion of US-FDA Inspection at Onesource, Unit-2 Doddaballapura, Bengaluru a manufacturing unit of the Company.
  Exchange Received Time 29-03-2025 17:07:15 Exchange Disseminated Time 29-03-2025 17:07:15 Time Taken 00:00:00
 
544292  |   Closure of Trading Window Insider Trading / SAST 2.26 MB XBRL
The trading window for dealing in the securities of the company is closed from April 01, 2025 untill 48 hours after the declaration of the financial results for the quarter and year ended .... Read More..
  Exchange Received Time 27-03-2025 15:54:13 Exchange Disseminated Time 27-03-2025 15:54:13 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Company Update 0.60 MB XBRL
Intimation of receipt of draft order under section 144 C (1) issued by the Assessment Unit, Income Tax Department, Ministry of Finance, Government of India pertaining to Assessment Year 2022-2023.
  Exchange Received Time 13-03-2025 12:42:34 Exchange Disseminated Time 13-03-2025 12:42:34 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update 0.70 MB XBRL
Intimation of investor meeting (physical) scheduled on March 07, 2025 at 4.00 P.M at Bengaluru, India.
  Exchange Received Time 03-03-2025 13:25:36 Exchange Disseminated Time 03-03-2025 13:25:36 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Press Release / Media Release Company Update 0.36 MB XBRL
Intimation of press release made by the Company on February 28,2025, w.r.t strengthening its Board by appointment of three new Independent directors.
  Exchange Received Time 28-02-2025 18:46:15 Exchange Disseminated Time 28-02-2025 18:46:15 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Change in Management Company Update 3.05 MB XBRL
Kindly refer to the enclosed file
  Exchange Received Time 27-02-2025 21:46:03 Exchange Disseminated Time 27-02-2025 21:46:03 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update 0.70 MB XBRL
Intimation of schedule of Investor meet to be held on March 7, 2025 at 09: 00.A.M.SGT at Singapore.
  Exchange Received Time 27-02-2025 13:08:58 Exchange Disseminated Time 27-02-2025 13:08:59 Time Taken 00:00:01
 
544292  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update 0.70 MB XBRL
Intimation of schedule of physical investor meeting dated March 04, 2025 and March 05, 2025 at 9:00 am at Mumbai, India.
  Exchange Received Time 27-02-2025 13:01:36 Exchange Disseminated Time 27-02-2025 13:01:36 Time Taken 00:00:00
 
544292  |   Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. Insider Trading / SAST 0.19 MB
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 21, 2025 for Tenshi Pharmaceuticals Pvt Ltd
  Exchange Disseminated Time 21-02-2025 18:14:24
 
544292  |   Announcement under Regulation 30 (LODR)-Credit Rating Company Update 0.73 MB XBRL
Intimation of Credit Rating issued by Care Ratings Limited vide press release dated February 20,2025
  Exchange Received Time 21-02-2025 17:39:36 Exchange Disseminated Time 21-02-2025 17:39:36 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Change in Management Company Update 1.26 MB XBRL
Intimation of cessation of Mr. Jason T Spacek, Chief Business Officer, w.e.f. February 20,2025, consequent to his termination, pursuant to Regulation 30 read with Schedule III of SEBI (LODR) .... Read More..
  Exchange Received Time 21-02-2025 17:22:02 Exchange Disseminated Time 21-02-2025 17:22:02 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update 0.70 MB XBRL
Intimation of schedule of Institutional Investors meet (physical meet) scheduled on Tuesday, February 25, 2025 at 9:00 am IST.
  Exchange Received Time 20-02-2025 15:43:45 Exchange Disseminated Time 20-02-2025 15:43:46 Time Taken 00:00:01
 
544292  |   Announcement under Regulation 30 (LODR)-Change in Management Company Update 0.61 MB XBRL
Appointment of Mr. Bernhard Thurnbauer as the Chief Quality Officer of the Company effective from March 01, 2025
  Exchange Received Time 14-02-2025 18:16:11 Exchange Disseminated Time 14-02-2025 18:16:11 Time Taken 00:00:00
 
544292  |   Intimation Of Financial Results For The Quarter Ended September 30,2024 In Reply To The Exchange Communication Company Update 1.36 MB XBRL
Intimation of financial results for the quarter and half year ended September 30,2024 in reply to the exchange communication.
  Exchange Received Time 06-02-2025 18:48:50 Exchange Disseminated Time 06-02-2025 18:48:50 Time Taken 00:00:00
 
544292  |   Intimation Of Transcript Of Investors Call Company Update 1.19 MB XBRL
Intimation of Transcript of the investors call held on January 29,2025.
  Exchange Received Time 04-02-2025 18:31:50 Exchange Disseminated Time 04-02-2025 18:31:50 Time Taken 00:00:00
 
544292  |   Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Insider Trading / SAST 0.29 MB
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tenshi Pharmaceuticals Pvt Ltd & Others
  Exchange Disseminated Time 03-02-2025 18:36:20
 
544292  |   Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Insider Trading / SAST 0.26 MB
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TIMF Holdings & Others
  Exchange Disseminated Time 31-01-2025 14:53:26
 
544292  |   Intimation Of Newspaper Advertisement Of Financial Results Company Update 3.05 MB XBRL
Intimation of newspaper advertisement of financial results for the quarter ended December 31,2024
  Exchange Received Time 30-01-2025 13:38:35 Exchange Disseminated Time 30-01-2025 13:38:35 Time Taken 00:00:00
 
544292  |   Intimation Of The Link Of The Audio Recording Of The Investor Call Held On 29Th January, 2025. Company Update 0.60 MB XBRL
Intimation of the link of the Audio recording as per Regulation 30 read with Part A Para A of Schedule III of the SEBI ( LODR) Regulations, 2015.
  Exchange Received Time 30-01-2025 11:22:38 Exchange Disseminated Time 30-01-2025 11:22:38 Time Taken 00:00:00
 
544292  |   Integrated Filing (Financial) Integrated Filing 3.15 MB XBRL
Financial Results for the quarter ended December 31, 2024
  Exchange Received Time 29-01-2025 19:57:23 Exchange Disseminated Time 29-01-2025 19:57:23 Time Taken 00:00:00
 
544292  |   Statement Of Investor Complaints For The Quarter Ended December 31, 2024 Company Update 0.70 MB XBRL
  Exchange Received Time 29-01-2025 19:27:41 Exchange Disseminated Time 29-01-2025 19:27:41 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Press Release / Media Release Company Update 2.30 MB XBRL
Reults for the quarter ended December 31, 2024
  Exchange Received Time 29-01-2025 07:46:01 Exchange Disseminated Time 29-01-2025 07:46:02 Time Taken 00:00:01
 
544292  |   Results-Financial Results For The Quarter Ended December 31. 2024 Result 2.82 MB XBRL
Quarterly results for the quarter ended December 31, 2024
  Exchange Received Time 29-01-2025 07:42:50 Exchange Disseminated Time 29-01-2025 07:42:50 Time Taken 00:00:00
 
544292  |   Board Meeting Outcome for Approval Of The Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended December 31, 2024 Board Meeting 2.71 MB XBRL
Approval of the Financial Results (Standalone and Consolidated) of the Company for the Quarter ended December 31, 2024
  Exchange Received Time 29-01-2025 07:37:28 Exchange Disseminated Time 29-01-2025 07:37:30 Time Taken 00:00:02
 
544292  |   Announcement under Regulation 30 (LODR)-Press Release / Media Release Company Update 1.03 MB XBRL
OneSource receives EIR with ''Voluntary Action Indicated'' classification from USFDA for its BLD Facility.
  Exchange Received Time 28-01-2025 21:32:25 Exchange Disseminated Time 28-01-2025 21:32:25 Time Taken 00:00:00
 
544292  |   Intimation Under Regulation 30(5) Of SEBI (LODR) Regulations, 2015 Company Update 0.58 MB XBRL
Intimation of the KMPs who are authorized for the purpose of determining materiallity of an event or information under Regulation 30(5) of the SEBI (LODR) Regulations, 2015
  Exchange Received Time 25-01-2025 12:45:10 Exchange Disseminated Time 25-01-2025 12:45:10 Time Taken 00:00:00
 
544292  |   As Per The Exchange Communication, Standalone & Consolidated Financial Results Of The Company For The Quarter Ended September 30, 2024 Company Update 1.34 MB XBRL
As per the Exchange communication, Standalone and Consolidated Financial Results of the Company for the quarter ended September 30, 2024
  Exchange Received Time 25-01-2025 00:11:25 Exchange Disseminated Time 25-01-2025 00:11:25 Time Taken 00:00:00
 
544292  |   Shareholding Pattern Of The Company For The Quarter Ended Spetember 30, 2024 Company Update 4.28 MB XBRL
Shareholding pattern for the quarter ended Spetember 30, 2024
  Exchange Received Time 25-01-2025 00:00:31 Exchange Disseminated Time 25-01-2025 00:00:31 Time Taken 00:00:00
 
544292  |   Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update 0.75 MB XBRL
Intimation of the Schedule of conference call with the Investors and analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  Exchange Received Time 24-01-2025 16:30:15 Exchange Disseminated Time 24-01-2025 16:30:16 Time Taken 00:00:01
 
544292  |   Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31,2024 Board Meeting 0.61 MB XBRL
Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 ,inter alia, to consider and approve Unaudited financial .... Read More..
  Exchange Received Time 24-01-2025 15:22:25 Exchange Disseminated Time 24-01-2025 15:22:26 Time Taken 00:00:01
 
544292  |   Listing of Equity Shares of Onesource Specialty Pharma Ltd New Listing
Trading Members of the Exchange are hereby informed that effective from January 24, 2025, the equity shares of Onesource Specialty Pharma Ltd (Scrip Code: 544292) are listed and admitted .... Read More..
  Exchange Disseminated Time 24-01-2025 08:08:22
 
     Current Page Number 1 out of 1



Site optimized for IE9 & above. | Disclaimer | Website Policies | Privacy Policy | Sitemap Copyright © BSE Ltd. All Rights Reserved.
31 Mar 25 | 08:54 (IST)
(22)